Life after hospital for cardiogenic shock survivors
Official title: Post-Acute Phase of Cardiogenic Shock (PACS) Registry
Run by Mackay Memorial Hospital · NCT07266675 · Data updated 2026-11-12
This project follows adults who survived cardiogenic shock after hospital discharge to see how they recover and what care they need.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | Mackay Memorial Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | July 19, 2024 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | December 5, 2025 |
| Trial ID | NCT07266675 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age 18 or older) who survive an episode of cardiogenic shock in hospital and agree to participate in follow-up are ideal candidates.
✕Probably not a fit
Patients who died during the hospital stay, are under 18, or who refuse follow-up are not eligible and would not receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter observational cohort that enrolls patients who survive cardiogenic shock to characterize their subacute course after hospital discharge. Participants will be followed with scheduled visits and data collection on clinical outcomes, healthcare use, and recovery to identify common challenges after discharge. The study aims to map care gaps and inform the development of a coordinated healthcare network to support safe return to the community. The design is observational and does not test an experimental treatment.
Why it matters
Potential benefit: If successful, the findings could lead to better coordinated post-discharge care and support services that reduce complications and readmissions for survivors of cardiogenic shock.
How similar studies have gone: Epidemiology has documented ongoing burden, but there are relatively few prospective cohorts focused specifically on the post-discharge subacute needs of cardiogenic shock survivors, so this approach is comparatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Hospital survivors of cardiogenic shock Exclusion Criteria: * Age \< 18 years。 * Patient or family refuse follow-up. * Patient died within hospital stay.
Where it's running
-
MacKay Memorial Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Cardiovascular department — Mackay Memorial Hospital
- Study coordinator: Shih-Chieh Chien, MD
- Email: sjay6277@gmail.com
- Phone: 0919601066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
-
Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients
This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.
-
Safety and Efficacy of an Extracorporeal Ventricular Assist System for Cardiogenic Shock
This study tests whether an extracorporeal ventricular assist device can safely provide short-term heart support and help patients with cardiogenic shock or trouble weaning from bypass.
-
Left Ventricular Support and Advanced Monitoring in AMI–Cardiogenic Shock: Immediate Impella Use and PAC/Monitoring vs Standard Care
In adults with heart attack-related cardiogenic shock, this trial tests whether using an Impella left ventricular assist device and/or protocolized pulmonary artery catheter monitoring improves survival compared with standard care.
-
CRP Apheresis for infarct-related cardiogenic shock
This study tests whether selectively removing C-reactive protein with apheresis, in addition to standard care, helps people with cardiogenic shock after a heart attack.
-
Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation
This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.